Prevention of Opioid Addiction
- 1 August 2021
- journal article
- Published by SciRes Literature LLC in Journal of Biomedical Research & Environmental Sciences
- Vol. 2 (8), 731-740
- https://doi.org/10.37871/jbres1304
Abstract
Opioid addiction is classified as a Substance Use Disorder (SUD), a complex and chronic health condition with physical, social, and psychological consequences. While there is no cure for it, we present a novel approach towards preventing a hallmark feature of addiction-- the opiate withdrawal syndrome. Opioids exert numerous effects, acutely and chronically, on the nervous system with physical dependence, tolerance, and withdrawal being the most adverse chronic features. The degree of opioid dependence can be quantified by the frequency and/or intensity of the behavioral expression of withdrawal seen after abrupt termination of opioid consumption or after treatment with an opioid antagonist such as naloxone. Although the Central Nervous System (CNS) is the primary area of opioid impact, the involvement of the immune system in modifying CNS phenomena was suggested nearly two centuries ago and proved by several groups within the last few decades. Through a series of studies with immunomodulators alpha interferon, cyclosporine A, and cortisol, preclinical experiments show that administration of these agents prior to chronic morphine exposure prevents the expression of opiate withdrawal a hallmark feature of addiction. This review provides updates on current developments in the management of the opioid epidemic and an overview of studies on preventative immunomodulation prior to repetitive opioid administration as a means of addressing one of the underlying symptomatology driving the epidemic.Keywords
This publication has 99 references indexed in Scilit:
- Nucleus accumbens neuronal activity in freely behaving rats is modulated following acute and chronic methylphenidate administrationBrain Research Bulletin, 2012
- Opioids and the treatment of chronic pain: Controversies, current status, and future directions.Experimental and Clinical Psychopharmacology, 2008
- CORTISOL AND HYPERTENSIONClinical and Experimental Pharmacology and Physiology, 1998
- Is interferon-α a neuromodulator?Brain Research Reviews, 1998
- Opium revisited: a brief review of its nature, composition, non‐medical use and relative risks1Addiction, 1997
- The mechanism of action of cyclosporin A and FK506Immunology Today, 1992
- The immune system and opiate withdrawalInternational Journal of Immunopharmacology, 1989
- Cyclophosphamide and cortisol reduce the severity of morphine withdrawalInternational Journal of Immunopharmacology, 1987
- Cyclosporine alters opiate withdrawal in rodentsLife Sciences, 1985
- Modification of morphine withdrawal by interferonLife Sciences, 1983